Alnylam Pharmaceuticals
ALNY
#634
Rank
$31.83 B
Marketcap
$246.80
Share price
-0.80%
Change (1 day)
50.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company